IBO Advisors Insights

What Actually Happens to Your Rollover Equity After You Sell to Private Equity

By Michael Chasen · Updated July 6, 2026

Two climbers roped to the same belay, one holding the other's weight

Most owners hear "rollover equity" for the first time in the same meeting where they're being told what their company is worth. It sounds like a technicality. It isn't. It's the private equity firm requiring you to reinvest a slice of your own sale proceeds back into the deal instead of taking it as cash - and that slice comes with its own separate set of odds, timelines, and risks that have nothing to do with the headline valuation you were just quoted.

What rollover equity actually is

Rollover equity is the portion of a seller's proceeds that gets reinvested into the acquiring entity rather than paid out in cash at closing. Instead of walking away with 100% cash, you keep a minority stake in the newly leveraged company, alongside the private equity sponsor that now controls it (Kubera). "Newly leveraged" is the operative phrase: the sponsor funds most of the purchase with debt placed on the company itself, so the stake you roll sits behind that debt in the capital structure. It also sits on a smaller base than the percentage suggests: a 30% roll in a deal financed at 3.5x EBITDA is 30% of the new equity, not 30% of the price, which is how a majority recapitalization can bank you 85% of enterprise value while still describing you as a 30% owner.

It isn't rare, and it isn't optional in most deals. Founder rollover now appears in roughly 70-85% of U.S. lower-middle-market PE buyouts as of 2026, up from about 55% in 2019 (CT Acquisitions, Founder Rollover Equity Benchmarks 2026). The typical size clusters between 10% and 40% of total consideration, with most lower-middle-market deals landing in the 15-30% range and larger deals often running higher (Windsor Drake; GHJ Advisors). One widely cited legal-industry average puts the typical rollover figure at close to 20% of deal consideration (Lexology). What you are rolling into is worth checking as carefully as how much: in healthcare services roll-ups, corporate-practice-of-medicine rules push the stake into a management services organization that holds the contracts and the economics, rather than into the practice you spent a career building.

Why sponsors require it

Private equity firms don't ask for rollover as a courtesy to sellers who want to stay involved. They require it because it aligns incentives in their favor: a seller with real money still riding on the company's future performance has less reason to hide problems in diligence, and more reason to keep working hard after the deal closes. It's a risk-transfer mechanism dressed up as a partnership offer.

That's a reasonable thing for a sponsor to want. It's a different thing for a seller to fully understand what they're actually signing up for. Whether the size of the rollover, the valuation it is struck at, and its exit terms get tested at all depends on who is running the process for you, which is the practical case for choosing an M&A advisor before you choose a buyer.

The "second bite of the apple" - on someone else's clock

The pitch sellers hear is some version of "take this bite now, and get a second bite later when we sell the company again." That second bite is real, but it happens on the private equity fund's timeline, not yours. Average holding periods for buyout-backed companies have stretched well past the traditional three-to-five-year window - global averages sat at roughly 6.6 years in 2025, and North American buyout funds have run even longer, averaging 7.1 years in 2023, the longest since at least 2000 (McKinsey Global Private Equity Report 2026; S&P Global Market Intelligence).

That means your rollover stake - the money you didn't take as cash at close - is illiquid for years, sitting inside a highly leveraged company, waiting on a fund manager's decision about when conditions are right for their own investors, not for you.

Rollover isn't the only slice at risk - earnouts compound the problem

Rollover equity often shows up in the same deal as an earnout: a portion of proceeds contingent on the company hitting performance targets after close, typically set by the new majority owner. The two mechanisms stack on top of each other, and the data on earnout payouts specifically should give any seller pause.

Across 2025 deals, average earnout payout ran to roughly 21 cents on the dollar of the maximum potential earnout amount, according to SRS Acquiom data (Kadenwood Group; S&P Global Market Intelligence). Breaking that down further: 41% of earnouts pay nothing at all, and among the 59% that do pay, roughly half of the maximum available is what lands (SRS Acquiom). Blending the zeros back in is how you get to the 21 cents. Earnout length matters too - 12-month earnouts pay out 68% on average, while 36-month earnouts pay out only 41% on average (CT Acquisitions).

Put those two mechanisms together - a 20-30% rollover held for a 6-7 year sponsor hold period, plus an earnout that on average pays out roughly a fifth of its stated maximum - and the gap between the headline number in your term sheet and the actual cash that eventually lands in your account can be substantial. That full ledger - multiple, rollover, earnout and tax - is worked through line by line in the pros and cons of selling to private equity, where a $35 million headline on an invented company comes back to about $19 million in hand. For the earnout half on its own - how the metric, the period and the efforts clause decide the outcome - see what an earnout in a business sale actually pays.

Rollover doesn't buy you a voice either

Here's the part that surprises sellers most: taking a rollover stake doesn't functionally give you a seat at the table. Minority equity holders in a PE-controlled company typically don't get board control - the sponsor retains that, along with veto rights over financing, major transactions, and the timing of any future sale (Umbrex Private Equity Glossary). You've reinvested real money into a company whose direction you no longer set. The mirror image is worth noting: in a minority recapitalization you are the one keeping the majority, which is a materially different position from rolling a minority slice into someone else's control deal. The percentage is not what settles it either way — how much of a business you can sell and still keep control turns on the board composition and the consent list in the shareholders' agreement, and those are negotiated separately from the number on the cap table.

How an Independent Buyout avoids this mechanism entirely

An Independent Buyout doesn't require a forced rollover to close a transaction. The company's own leadership team becomes the buyer, financed against the business itself using a mechanism that's been part of the federal tax code since 1984 under Internal Revenue Code Section 1042 (Cornell Law School, 26 U.S. Code § 1042). Depending on your specific facts, proceeds can potentially be structured for tax-advantaged treatment - always confirm the specifics with your own tax advisor. There's no outside sponsor's hold-period clock, and no minority stake held hostage to someone else's fund cycle. It is one of several alternatives to selling to private equity that don't require you to reinvest your own proceeds to get the deal done.

Frequently asked questions

Is rollover equity the same as an earnout? No. Rollover equity is ownership you keep in the company; an earnout is a deferred cash payment contingent on hitting performance targets. Many PE deals include both, and each carries its own separate risk of underdelivering against what a seller initially expects.

Can I negotiate out of a rollover requirement? Sometimes, but most sponsors treat rollover as a condition of the deal, not a negotiable extra - particularly for founders who will remain operationally involved. Rolling less than roughly 10-20% can signal weak seller conviction to a buyer evaluating the deal.

How long is my rollover stake typically illiquid? Until the sponsor exits the company, which now averages roughly 6.5-7 years for buyout-backed companies - longer than the traditional three-to-five-year hold that many sellers still assume going in.

Does a small rollover stake still come with board influence? Rarely in a controlling capacity. Minority holders typically get information rights or, above certain ownership thresholds, an observer or director seat - but the sponsor retains veto authority over the decisions that matter most.

Does an Independent Buyout require any rollover at all? No. It can be structured around the seller's own liquidity goals rather than a sponsor-imposed reinvestment requirement, which is one of the core structural differences from a private equity sale.

Sources

The bottom line

Rollover equity isn't free upside on top of your sale price - it's a reinvestment of your own proceeds into a company you no longer control, held for years on a sponsor's timeline, often stacked with an earnout that pays out a fraction of what it advertises. Run the actual math on your specific rollover and earnout terms before you sign - starting from a defensible valuation range for your business - and weigh it against a structure that doesn't require the reinvestment in the first place.

If your company is doing $3M+ in EBITDA and you want to understand what a rollover requirement in your specific deal would actually mean for your liquidity, talk to IBO Advisors about your business.

Curious whether an Independent Buyout fits your business?

Learn More